Therefore, CADM1 expression is dependent on the activation of the NF-κB signaling pathway through the activation of NF-κB-like binding sequences at the CADM1 promoter in ATLL cells. This evidence concerns the gene CADM1 and adult T-cell leukemia/lymphoma.